NxThera Lands $9,000,000 Series B Funding Round

  • Feed Type
  • Date
    10/5/2011
  • Company Name
    NxThera
  • Mailing Address
    4186 Lexington Ave. St. Paul, MN 55126
  • Company Description
    NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company’s technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life.
  • Website
    http://www.nxthera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Funds raised will be used to obtain European CE Mark approval and U.S. Food and Drug Administration clearance for a clinical study for the Rezum vapor ablation device in Europe, Canada and the United States, and to develop additional endourology devices.
  • M&A Terms
  • Venture Investor
    American Medical Systems
  • Venture Investor
    Mitsui & Co. Venture Partners
  • Venture Investor
    Prolog Ventures
  • Venture Investor
    Alafi Capital

By posting a comment, you agree to our terms and conditions.